VPIM
BCYC

Vanguard Personalized Indexing Management’s Bicycle Therapeutics BCYC Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,776
Closed -$90.5K – 2174
2025
Q4 		$90.5K Sell
12,776
-177
-1% -$1.3K ﹤0.01% 1818
2025
Q3 		$100K Buy
+12,953
New +$97.8K ﹤0.01% 1819

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Personalized Indexing Management's BCYC Position: Q1 2026 in Review

Vanguard Personalized Indexing Management sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 12,776 shares — an estimated $90.5K sold.

Vanguard Personalized Indexing Management first reported a position in BCYC in Q3 2025 and held it in 2 quarters. The position peaked at $100K in Q3 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Vanguard Personalized Indexing Management reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 12,776 Bicycle Therapeutics shares in Q1 2026, an estimated $90.5K.
  • Vanguard Personalized Indexing Management first reported a position in Bicycle Therapeutics in Q3 2025 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's Bicycle Therapeutics position peaked at $100K in Q3 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.